Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CBC201
- Development stage
- Preclinical
- Lead developer
- Blue Lake Biotechnology
- Modality
- Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
CBC201 is a preclinical-stage vaccine candidate being developed by CliPSBnC for the prevention of respiratory syncytial virus (RSV) infection. The vaccine is built upon the company's proprietary Clinical Protein System (CliPS) platform, which utilizes protein-based nanoparticle technology to enhance the stability and immunogenicity of viral antigens. By presenting RSV-specific antigens in a highly organized nanoparticle format, CBC201 is designed to elicit a potent and durable immune response, including the production of neutralizing antibodies. The primary goal of the program is to provide a protective solution against RSV-induced lower respiratory tract infections, which pose a significant health risk to infants, young children, and the elderly.
- Other names
- CliPSBnC RSV vaccine
Beyond the preview
Go deeper on CBC201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CBC201.